immunity News and Research

RSS

What is the long-term protection against COVID-19?

A new study describes the immunologic parameters associated with protection from COVID-19.

12 Jul 2022

Scientists investigate impact of SARS-CoV-2 RBD mutations across variants

In a recent study posted to the medRxiv* pre-print server, Australian researchers comprehensively investigated the impact of 39 receptor-binding-domain (RBD) mutations in six severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and variants of interest (VOIs).

12 Jul 2022

Persistence of SARS-CoV-2 in tissues leads to long COVID

PASC is likely the result of long-term persistence of SARS-CoV-2 in various tissues

11 Jul 2022

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

Immunotherapy has revolutionized treatment for many forms of cancer, but glioblastoma multiforme (GBM), the most common and deadly form of brain cancer, has remained untouched.

11 Jul 2022

Immune response after mild COVID

In a recent study posted to the medRxiv* preprint server, researchers in Germany assessed the immunity elicited by a mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

10 Jul 2022

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.

8 Jul 2022

Universal influenza B vaccine confers robust and sustained cross-immune protection

A new universal flu vaccine protects against influenza B viruses, offering broad defense against different strains and improved immune protection, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

8 Jul 2022

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Researchers at the University of São Paulo (USP) in Brazil analyzed data from 43 scientific articles describing the effects of COVID-19 on athletes and concluded that while the disease was asymptomatic or mild in the vast majority of cases (94%), about 8% of the subjects concerned had persistent symptoms affecting their performance and potentially preventing a return to training and competing.

8 Jul 2022

What is the long-term vaccine effectiveness against SARS-CoV-2 infection?

A new study aimed to estimate the waning of vaccine protection by performing a systematic literature review of studies that reported VE at different times post-vaccination.

8 Jul 2022

The strength and breadth of antibody responses elicited by hybrid immunity to COVID-19 vaccination or infection alone

Researchers assessed neutralizing antibody responses to SARS-CoV-2 after receiving one dose of vaccine.

8 Jul 2022

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

A recent study published in the Science journal depicted that mosaic receptor-binding domain (RBD) nanoparticles immunize from diverse sarbecovirus challenges, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), among animal models.

8 Jul 2022

Research assesses antigenic co-evolution of SARS-CoV-2 variants

In a recent study posted to the bioRxiv* preprint server, researchers analyzed antigenic variety across the significant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, like Omicron lineages.

8 Jul 2022

Antibodies transmitted through breast milk persist six months after COVID mRNA vaccination

Researchers describe the effects of COVID-19 vaccines in lactating mothers and relates their antibody response to the protection of their children.

7 Jul 2022

After 3 doses of COVID vaccine, most cancer patients retain detectable humoral immunity

In a recent study posted to the medRxiv* preprint server, researchers assessed the efficacy and durability of immune responses to the third dose of coronavirus disease 2019 (COVID-19) vaccines. They also assessed the efficacy of the fourth vaccine dose among severely immunocompromised patients with hematological malignancies.

7 Jul 2022

Human milk immune activity may both lower and increase infants’ infectious disease risk

Researchers discuss the short-term effects of the immune system of breast milk on infant health.

7 Jul 2022

Scientists identify molecules promoting plant immunity

Two studies published by researchers at the Max Planck Institute for Plant Breeding Research in Cologne, Germany in collaboration with colleagues in China have discovered natural cellular molecules that drive critical plant immune responses.

7 Jul 2022

Novel COVID-19 antibody delivery approach advances to clinical trials

Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) funded program, a novel COVID-19 antibody delivery approach has advanced to clinical trials.

7 Jul 2022

Broadness of neutralizing antibodies to sarbecoviruses depends on priming conditions

In a recent study under review at the Nature Portfolio journal and currently available on the Research Square* preprint server, researchers identified immune priming conditions that generated broadly neutralizing antibody (nAb) responses and assessed immunity post-third dose of coronavirus disease 2019 (COVID-19) vaccines such as BNT126b2 or Coronavac vaccines after two homologous doses of BNT126b2 or Coronavac vaccines.

7 Jul 2022

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system's history with other coronaviruses, including those behind the common cold, shapes the patient's response, according to a study published today in Cell Reports.

6 Jul 2022

COVID-19 vaccination with bacterial peptide conjugated to receptor-binding domain elicits potent immune response

In a new study, researchers assessed the efficiency of immunization with a bacterial peptide conjugated to the SARS-CoV-2 receptor-binding domain against SARS-CoV-2 infection.

6 Jul 2022

immunity News and Research

What is the long-term protection against COVID-19?

Scientists investigate impact of SARS-CoV-2 RBD mutations across variants

Persistence of SARS-CoV-2 in tissues leads to long COVID

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

Immune response after mild COVID

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

Universal influenza B vaccine confers robust and sustained cross-immune protection

Researchers analyze acute and post-acute COVID-19 presentations in athletes

What is the long-term vaccine effectiveness against SARS-CoV-2 infection?

The strength and breadth of antibody responses elicited by hybrid immunity to COVID-19 vaccination or infection alone

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

Research assesses antigenic co-evolution of SARS-CoV-2 variants

Antibodies transmitted through breast milk persist six months after COVID mRNA vaccination

After 3 doses of COVID vaccine, most cancer patients retain detectable humoral immunity

Human milk immune activity may both lower and increase infants’ infectious disease risk

Scientists identify molecules promoting plant immunity

Novel COVID-19 antibody delivery approach advances to clinical trials

Broadness of neutralizing antibodies to sarbecoviruses depends on priming conditions

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

COVID-19 vaccination with bacterial peptide conjugated to receptor-binding domain elicits potent immune response

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News